Publication | Closed Access

Aspartate aminotransferase-to-platelet ratio predicts response to transarterial chemoembolisation and prognosis in hepatocellular carcinoma patients

ThrombosisHepatologyHepatocellular Carcinoma PatientsBlood PlateletTransarterial ChemoembolisationLiver PhysiologyMedicinePathologyLiver CancerAspartate Aminotransferase-to-platelet RatioPlatelet AntagonistOncologyHepatocellular CarcinomaCancer ResearchRadiologyHealth Sciences